Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.379ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.379ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.379EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.379EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.379ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.379ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.78EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.78EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.78ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.78ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.78EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.78EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.78ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.78ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.16EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.16EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.16ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.16ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.16EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.16EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.16ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.16ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XAEWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
XAEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XAECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
XAECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XAEHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XAEHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XAENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XAENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AZ.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AZ.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AZ.4ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
AZ.4ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
AZ.4EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
AZ.4EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AZ.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AZ.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.114EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.114EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.114ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.114ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.114EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.114EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.114ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.114ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.39EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.177.39EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.39ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.177.39ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used